| Dokumendiregister | Sotsiaalministeerium |
| Viit | 1.4-2/617-1 |
| Registreeritud | 04.03.2025 |
| Sünkroonitud | 05.03.2025 |
| Liik | Sissetulev kiri |
| Funktsioon | 1.4 EL otsustusprotsess ja rahvusvaheline koostöö |
| Sari | 1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik) |
| Toimik | 1.4-2/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | World Health Organization |
| Saabumis/saatmisviis | World Health Organization |
| Vastutaja | Helen Sõber (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond) |
| Originaal | Ava uues aknas |
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.2.2025
The World Health Organization presents its compliments and has the honour to transmit, in
accordance with Article 3 of the “Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances”,1 the following list of proposed International Nonproprietary Names (prop. INN) which has been published by the World Health Organization in WHO Drug Information, Vol. 38, No. 4, 2024 on the WHO website at: WHO Drug Information, vol. 38, 4 [full issue]:
– p.INN list 132 from p. 1015 to 1307 (deadline for objecting and commenting is 13 June 2025)
It would be appreciated if this communication could be forwarded to the appropriate patent and trade-mark office and to any other organization dealing with the introduction of nonproprietary names for pharmaceutical substances. Any comments that may be made, or notifications of a conflict between proposed names and existing proprietary rights, should be addressed to the INN Programme ([email protected]), World Health Organization, 1211 Geneva 27, within four months following the publication of the above-mentioned journal.
The selection of international nonproprietary names by the World Health Organization for use in all Member States presents many difficulties. It would therefore be appreciated if this were borne in mind when it is contemplated to exercise the right to raise objections.
Furthermore, the World Health Organization would be grateful if, in the interest of public health and pursuant to the procedure referred to in the first paragraph of this communication, the above-mentioned list of names could be granted protection in Member States during the period they are under consideration by the World Health Organization as international nonproprietary names.
GENEVA, 3 March 2025
1 Annex to resolution EB15.R7, Off. Rec. Wld Hlth Org., No. 60, pp. 3 and 55. This text was amended by
resolution EB43.R9, Off. Rec. Wld Hlth Org., No. 173, p. 10 and resolution EB115.R4, Executive Board, 115th Session, Resolutions and Decisions (EB115/2005/REC/1), p. 2.
Saatja: <[email protected]>
Saadetud: 04.03.2025 15:28
Koopia: <[email protected]>
Teema: WHO: C.L.2.2025 (Proposed INN list 132)
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.Tundmatu saatja
korral palume linke ja faile mitte avada.Tähelepanu! Tegemist on
välisvõrgust saabunud kirjaga.Tundmatu saatja korral palume linke ja
faile mitte avada.Dear Member States of the World Health
Organization,Please find attached, in the six official languages,
C.L.2.2025 regarding the proposed list 132 of International
Nonproprietary Names for Pharmaceutical Substances.Should you have
questions regarding C.L.2.2025 please send an email to
[email protected] regards,Department of Governing BodiesWorld
Health Organization***DO NOT RESPOND TO THIS E-MAIL. YOU WILL NOT RECEIVE
A REPLY***